Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.
Saved in:
| Title: | Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors. |
|---|---|
| Authors: | Nelson BE; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Janku F; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Fu S; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Dumbrava EE; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Hong DS; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Karp DD; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Naing A; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Rodon J; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Tsimberidou AM; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas., Murthy R; Department of Interventional Radiology, U.T. M.D. Anderson Cancer Center, Houston, Texas., Sheth RA; Department of Interventional Radiology, U.T. M.D. Anderson Cancer Center, Houston, Texas., Amaria RN; Department of Melanoma Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas., Conley AP; Department of Sarcoma Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas., Damodaran S; Department of Breast Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas., Raghav KPS; Department of Gastrointestinal Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas., Carapanceanu N; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Singh MP; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Carapanceanu V; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Pezeshki A; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Leontovich AA; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Kreider BL; Biomed Valley Discoveries, Kansas City, Missouri., Tung D; Biomed Valley Discoveries, Kansas City, Missouri., Varterasian M; Biomed Valley Discoveries, Kansas City, Missouri., Khazaie K; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Piha-Paul SA; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Sep 15; Vol. 31 (18), pp. 3864-3875. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40643985 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nelson+BE%22">Nelson BE</searchLink>; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Janku+F%22">Janku F</searchLink>; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Fu+S%22">Fu S</searchLink>; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Dumbrava+EE%22">Dumbrava EE</searchLink>; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Hong+DS%22">Hong DS</searchLink>; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Karp+DD%22">Karp DD</searchLink>; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Naing+A%22">Naing A</searchLink>; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Rodon+J%22">Rodon J</searchLink>; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Tsimberidou+AM%22">Tsimberidou AM</searchLink>; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Murthy+R%22">Murthy R</searchLink>; Department of Interventional Radiology, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Sheth+RA%22">Sheth RA</searchLink>; Department of Interventional Radiology, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Amaria+RN%22">Amaria RN</searchLink>; Department of Melanoma Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Conley+AP%22">Conley AP</searchLink>; Department of Sarcoma Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Damodaran+S%22">Damodaran S</searchLink>; Department of Breast Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Raghav+KPS%22">Raghav KPS</searchLink>; Department of Gastrointestinal Medical Oncology, U.T. M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Carapanceanu+N%22">Carapanceanu N</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Singh+MP%22">Singh MP</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Carapanceanu+V%22">Carapanceanu V</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Pezeshki+A%22">Pezeshki A</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Leontovich+AA%22">Leontovich AA</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Kreider+BL%22">Kreider BL</searchLink>; Biomed Valley Discoveries, Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Tung+D%22">Tung D</searchLink>; Biomed Valley Discoveries, Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Varterasian+M%22">Varterasian M</searchLink>; Biomed Valley Discoveries, Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Khazaie+K%22">Khazaie K</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Piha-Paul+SA%22">Piha-Paul SA</searchLink>; Department of Investigational Cancer Therapeutics, U.T. M.D. Anderson Cancer Center, Houston, Texas. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2025 Sep 15; Vol. 31 (18), pp. 3864-3875. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40643985 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1078-0432.CCR-24-3952 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3864 Titles: – TitleFull: Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nelson BE – PersonEntity: Name: NameFull: Janku F – PersonEntity: Name: NameFull: Fu S – PersonEntity: Name: NameFull: Dumbrava EE – PersonEntity: Name: NameFull: Hong DS – PersonEntity: Name: NameFull: Karp DD – PersonEntity: Name: NameFull: Naing A – PersonEntity: Name: NameFull: Rodon J – PersonEntity: Name: NameFull: Tsimberidou AM – PersonEntity: Name: NameFull: Murthy R – PersonEntity: Name: NameFull: Sheth RA – PersonEntity: Name: NameFull: Amaria RN – PersonEntity: Name: NameFull: Conley AP – PersonEntity: Name: NameFull: Damodaran S – PersonEntity: Name: NameFull: Raghav KPS – PersonEntity: Name: NameFull: Carapanceanu N – PersonEntity: Name: NameFull: Singh MP – PersonEntity: Name: NameFull: Carapanceanu V – PersonEntity: Name: NameFull: Pezeshki A – PersonEntity: Name: NameFull: Leontovich AA – PersonEntity: Name: NameFull: Kreider BL – PersonEntity: Name: NameFull: Tung D – PersonEntity: Name: NameFull: Varterasian M – PersonEntity: Name: NameFull: Khazaie K – PersonEntity: Name: NameFull: Piha-Paul SA IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 09 Text: 2025 Sep 15 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1557-3265 Numbering: – Type: volume Value: 31 – Type: issue Value: 18 Titles: – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research Type: main |
| ResultId | 1 |